
Meeting Abstract: 2024 ASCO Genitourinary Cancers Symposium
Background: Acute kidney injury (AKI) is a frequent complication in patients with muscle-invasive bladder cancer (MIBC) who undergo radical cystectomy (RC). Previous studies have reported that AKI during cancer treatment was associated with poor oncological outcomes in …
Acute kidney injury and major outcomes in cancer patients with no ...
Background: Acute Kidney Injury (AKI) in patients with COVID-19 infection is associated with poor clinical outcomes. We examined outcomes (hemodialysis, mechanical ventilation, ICU admission and death) in cancer patients with normal estimated glomerular filtration rate (eGFR) treated in a tertiary referral center with COVID-19 infection, who ...
Immune Checkpoint Inhibitors and Kidney Toxicity: Advances in …
However, the combination of cytotoxic T lymphocyte antigen-4 and PD-1 inhibitors, used to induce a more durable response in cancers such as non–small cell lung cancer, melanoma, or renal cell carcinoma, carries a higher risk of ICI-induced AKI (∼5%) due to the blockade of 2 different checkpoint pathways. 6, 10, 11, 12 The most recently ...
Factors associated with acute kidney injury among ... - ASCO …
2022年6月2日 · AKI was defined by a rise in the concentration of serum creatinine as per Kidney Disease: Improving Global Outcomes (KDIGO) criteria. A multivariable regression model was used to identify predictors of AKI while accounting for the competing risk of death.
Effect of acute kidney injury on hospital-based outcomes in …
In this study we utilize the National Inpatient Sample (NIS) to understand the effect of acute kidney injury (AKI) on inpatient mortality in multiple myeloma patients. Methods: This is a retrospective study utilizing the data obtained from the NIS for the year 2018.
Meeting Abstract: 2019 ASCO Annual Meeting I - ASCO Publications
2019年5月26日 · AKI may occur due to direct injury from primary cancer, nephrotoxic effects of chemotherapy, hematopoietic stem-cell transplantation or following comorbidities like sepsis and metabolic disturbance. AKI is associated with prolonged hospital stay, high healthcare cost and increased mortality in critically ill patients.
ASCO GU 2025: Evaluation of Circulating Kidney Injury Marker-1 …
Wenxin Xu presented a post-hoc analysis of CheckMate 214 evaluating circulating kidney injury marker-1 as a prognostic and predictive biomarker in advanced renal cell carcinoma (RCC). CheckMate 214 demonstrated that the combination of nivolumab + ipilimumab has superior overall survival and durable responses, compared to sunitinib, with 8 years ...
Immunotherapy in oncology and the kidneys: a clinical review of …
2023年1月28日 · ASCO guidelines recommend treating patients empirically with steroids when suspicion of ICI-related AKI is high and no other obvious causes of AKI have been found. Kidney biopsy should be considered only if the AKI is refractory to …
A single-institution study of renal outcomes in patients receiving ...
Primary endpoint was acute kidney injury (AKI), defined as increase in serum creatinine by > 0.3 mg/dL or ≥ 50% from baseline. Results: 206 patients were selected with most common diagnoses of melanoma (81%) or NSCLC (12%). Most patients (79%) also had stage 4 disease.
Checkpoint inhibitor therapy-associated acute kidney injury: …
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment since their introduction ∼15 years ago. However, these monoclonal antibodies are associated with immune-related adverse events that can also affect the kidney, resulting in acute kidney injury (AKI), which is most commonly due to acute tubulointerstitial nephritis (ATIN).